-
The pattern of the innovative drug industry has become clearer, and there are three points in the layout logic
Time of Update: 2023-01-06
The industry believes that the core of medical insurance is still to encourage innovation, and since the national policy of supporting the development of innovative drugs in 2015, some domestic innovative drugs that appeared in 2018-2019 are some generic innovations that lack special value.
-
The pattern of the innovative drug industry has become clearer, and there are three points in the layout logic
Time of Update: 2023-01-06
The industry believes that the core of medical insurance is still to encourage innovation, and since the national policy of supporting the development of innovative drugs in 2015, some domestic innovative drugs that appeared in 2018-2019 are some generic innovations that lack special value.
-
How can anaphylaxis be diagnosed and treated quickly? Remember these 4 points to help
Time of Update: 2022-10-03
Table 3 Contraindications and adverse reactions of epinephrine Table4 Selection of epinephrine route of administration [1-4]▎Inhaled β2 receptor agonist short-acting β2 receptor agonist can be used as a second-line drug for the treatment of severe allergic reactions, with bronchospasm, dyspnea, Patients with stridors may inhale short-acting beta2-agonists (eg, salbutamol).
-
The pace of approval and marketing of domestic innovative drugs will continue to accelerate, bursting out more new vitality
Time of Update: 2022-05-08
The industry predicts that 19 blockbuster new drugs will be approved in 2022, and two of the 19 innovative drugs will be independently developed by domestic pharmaceutical companies .
-
Experts comment on Nat Immunol | Overcoming T cell depletion-Metabolic reprogramming releases great potential for tumor immunotherapy to treat solid tumors
Time of Update: 2021-06-01
The study further confirmed that IL-10–Fc promotes the proliferation of terminally depleted T cells and their anti-tumor immune response by enhancing mitochondrial pyruvate carrier (MPC)-dependent oxidative phosphorylation (OXPHOS), which has significantly expanded The scope of application of T cell-dependent tumor immunotherapy.
-
The new modified drug 505 (b) (2) offers great opportunities in China
Time of Update: 2020-08-03
at present, the domestic pharmaceutical industry policy environment encourages the development of new modified drugs, to achieve improvement and innovation, to meet clinical needs.
-
A large number of hospitals stop using 20 heavy varieties
Time of Update: 2019-12-12
Fujian has always been the experimental field and pioneer army of medical reform pilot, whether in Sanming mode or in the first linkage of 4 + 7, which endows the province with the temperament and sty
-
Four Enlightenments of 16 strongest new drugs to enterprises
Time of Update: 2019-06-03
One way to measure the importance of a new drug is how quickly it can replace an existing product on the market, which is a key indicator Strong commercial promotion usually indicates that a new drug
-
It's the stone of the mountain. It can be used to attack the jade. There are three kinds of chemical drugs
Time of Update: 2016-09-23
In 2015, Nanjing Huawei Pharmaceutical Technology Development Co., Ltd applied for the largest number of class 3 new chemicals, followed by Ruiyang Pharmaceutical Co., Ltd applied for 50; Jiangsu aosaikang Pharmaceutical Co., Ltd applied for 44 Table 3 2015 application for more than 7 chemical and pharmaceutical category 3 enterprises list summit special interface link: http://news.yaozh.com/zhuanti/detail.html?
-
CFDA states that new drug approvals will be accelerated or government purchase services will be adopted
Time of Update: 2014-11-06
Source: Southern Metropolis Daily on November 6, 2014, Yin Li, deputy director of the State Food and drug administration, said that the government's purchase of services will become an important means
-
Price of xiaopingbei in Qingping market rose by one or twenty times as high as that of Chuanbei
Time of Update: 2013-08-30
At the beginning of July this year, the State Food and Drug Administration conducted a secret visit to 5 of the 17 professional markets of Chinese herbal medicines, and found that the results were "se